Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection
暂无分享,去创建一个
T. Molina | A. Fischer | C. Picard | S. Ehl | L. Galicier | D. Boutboul | S. Latour | B. Neven | J. Bruneau | S. Blanche | D. Moshous | F. Suarez | H. Delecluse | Sarah Winter | V. Barlogis | B. Terrier | C. Miot | B. Dunogué | M. Malphettes | I. Pellier | B. Fournier | M. Castelle | Cécile Boulanger | Charline Miot
[1] Smita Y. Patel,et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. , 2020, JCI insight.
[2] S. Hue,et al. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. , 2019, Pathology.
[3] A. Fischer,et al. Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells , 2019, The Journal of experimental medicine.
[4] A. Fischer,et al. Signaling pathways involved in the T‐cell‐mediated immunity against Epstein‐Barr virus: Lessons from genetic diseases , 2019, Immunological reviews.
[5] S. Tsao,et al. Epstein–Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production , 2019, Nature Microbiology.
[6] F. Collins,et al. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in Caucasians. , 2019, Blood.
[7] Jiali Cheng,et al. Determination of Epstein-Barr Virus–Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases , 2019, Open forum infectious diseases.
[8] L. Quintanilla‐Martinez,et al. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases , 2019, Front. Pediatr..
[9] Y. Kwong,et al. EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment , 2019, Front. Oncol..
[10] A. Arai. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development , 2019, Front. Pediatr..
[11] Masahiro Yoshida,et al. Defective Epstein–Barr virus in chronic active infection and haematological malignancy , 2019, Nature Microbiology.
[12] M. Inoue,et al. Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders , 2018, Front. Pediatr..
[13] C. Bollard,et al. How I treat T-cell chronic active Epstein-Barr virus disease. , 2018, Blood.
[14] S. Latour,et al. Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases , 2018, Front. Immunol..
[15] D. Heo,et al. CD21-independent Epstein-Barr virus entry into NK cells. , 2018, Cellular immunology.
[16] Y. Oki,et al. Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma , 2018, Front. Oncol..
[17] H. Tagawa,et al. A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features , 2017, Haematologica.
[18] J. Todd,et al. Neonatal and adult recent thymic emigrants produce IL-8 and express complement receptors CR1 and CR2 , 2017, JCI insight.
[19] Robert E. White,et al. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. , 2017, Cell host & microbe.
[20] K. Kawa,et al. How we treat chronic active Epstein–Barr virus infection , 2017, International Journal of Hematology.
[21] S. Tangye,et al. Human immunity against EBV—lessons from the clinic , 2017, The Journal of experimental medicine.
[22] A. Fischer,et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70–CD27 pathway in immunity to Epstein-Barr virus infection , 2017, The Journal of experimental medicine.
[23] C. Rongyi,et al. Hydroa vacciniforme-like lymphoma , 2016, QJM : monthly journal of the Association of Physicians.
[24] M. Plummer,et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.
[25] B. McFarlin,et al. Measurement of Low‐Abundance Intracellular mRNA Using Amplified FISH Staining and Image‐Based Flow Cytometry , 2016, Current protocols in cytometry.
[26] Sin-Ho Jung,et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. , 2016, The Lancet. Oncology.
[27] Thierry Fest,et al. GenomicScape: An Easy-to-Use Web Tool for Gene Expression Data Analysis. Application to Investigate the Molecular Events in the Differentiation of B Cells into Plasma Cells , 2015, PLoS Comput. Biol..
[28] M. Rowe,et al. Unexpected patterns of Epstein–Barr virus transcription revealed by a High throughput PCR array for absolute quantification of viral mRNA , 2015, Virology.
[29] A. Fischer,et al. CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation , 2014, Nature.
[30] T. Murata,et al. Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation , 2014, Cancer medicine.
[31] L. Quintanilla‐Martinez,et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. , 2013, Blood.
[32] S. Tracy,et al. The pathogenesis of Epstein-Barr virus persistent infection. , 2013, Current opinion in virology.
[33] T. Kinoshita,et al. Application of flow cytometric in situ hybridization assay to Epstein–Barr virus‐associated T/natural killer cell lymphoproliferative diseases , 2012, Cancer science.
[34] T. Naoe,et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. , 2012, Blood.
[35] D. Douek,et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency , 2011, Nature.
[36] T. Cenci,et al. The Viral Load of Epstein–Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma , 2011, Clinical Cancer Research.
[37] Y. Yamauchi,et al. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. , 2009, The Journal of infectious diseases.
[38] S. Tangye,et al. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. , 2008, Blood.
[39] T. Greenough,et al. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. , 2008, Blood.
[40] Mark Ende,et al. Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.
[41] S. Pittaluga,et al. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. , 2006, The Journal of clinical investigation.
[42] Richard C Brundage,et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. , 2005, The Journal of infectious diseases.
[43] T. Pawson,et al. The Epstein-Barr Virus Protein, Latent Membrane Protein 2A, Co-opts Tyrosine Kinases Used by the T Cell Receptor* , 2005, Journal of Biological Chemistry.
[44] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[45] M. Gulley,et al. Epstein-Barr Virus (EBV) DNA in Plasma Is Not Encapsidated in Patients With EBV-Related Malignancies , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[46] D. Thorley-Lawson,et al. Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells , 2004, Journal of Virology.
[47] E. Joly,et al. What is trogocytosis and what is its purpose? , 2003, Nature Immunology.
[48] P. Brousset,et al. Acquisition of Viral Receptor by NK Cells Through Immunological Synapse1 , 2003, The Journal of Immunology.
[49] R. Freeman,et al. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. , 2002, Immunity.
[50] W. Hammerschmidt,et al. The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators , 2000, The EMBO journal.
[51] D. Thorley-Lawson,et al. A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. , 1999, Life sciences.
[52] R. Freeman,et al. Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients , 1999, The Journal of experimental medicine.
[53] L. Kunz-Schughart,et al. Epstein-Barr Virus Small RNA (EBER) Genes: Differential Regulation during Lytic Viral Replication , 1998, Journal of Virology.
[54] W. Hammerschmidt,et al. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Chan,et al. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+. , 1996, Blood.
[56] U. Nater,et al. Epstein-Barr virus. , 1991, The Journal of family practice.
[57] L. Resnick,et al. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Steitz,et al. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. Feederle,et al. Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types. , 2015, Current topics in microbiology and immunology.
[60] R. Advani,et al. The World Health Organization Classification of Lymphoid Neoplasms , 2013 .
[61] Y. Nishiyama,et al. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. , 2010, The Journal of general virology.